LATEST ALERTS
The US Food and Drug Administration has sent warning letters to 189 retailers as part of its efforts to police sales of disposable vapes. It has also highlighted Centers for Disease Control and Prevention studies
Our weekly podcast brings you a summary of the ECigIntelligence daily alerts, covering key developments in law and regulation surrounding e-cigarettes and vaping
Our weekly podcast brings you a summary of the ECigIntelligence daily alerts, covering key developments in law and regulation surrounding e-cigarettes and vaping
Tobacco giant Altria confirmed it had completed its acquisition of e-cigarette maker Njoy for $2.75bn, having cleared antitrust checks in the US
Action against disposable e-cigarettes continues in the US, with the Food and Drug Administration (FDA) issuing warning letters to 30 retailers over sales of the popular Puff and Hyde brands
The US Food and Drug Administration (FDA) has issued warning letters to the manufacturers of Breeze and Esco Bars disposable vape products to protect young people against illegal flavoured disposable e-cigarette products
US authorities have started to say the science indicates any youth vaping “epidemic” is now over and they should start making policy decisions that suit the real-world trend, according to a free-market think tank
The Reagan-Udall Foundation’s reports on the US Food and Drug Administration (FDA) provide “substantially different future policy implications” for the different FDA programs investigated
Our weekly podcast brings you a summary of the ECigIntelligence daily alerts, covering key developments in law and regulation surrounding e-cigarettes and vaping
This report analyses an apparently change in the FDA’s review process for PMTAs, and discusses a number of individual cases where companies have raised it following the issuing of an MDO
Philip Morris International will scale back and partially outsource its vaping business, instead focusing on other tobacco alternatives that can help it become a majority smoke-free revenue company by 2025
A US House of Representatives committee has launched an investigation into the Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) for alleged failure to effectively regulate nicotine products
This report examines the US Food and Drug Administration proposed rule that would establish a unified regulatory framework for tobacco product manufacturing practice requirements
A US court has allowed RJ Reynolds Vapor Company to continue selling its Vuse menthol e-cigarette products after the FDA issued marketing denial orders against them last week
The US Food and Drug Administration (FDA) has refused marketing authorisation for around 17m e-liquid products because the company behind the application did not provide the required environmental assessments
The US Food and Drug Administration has issued marketing denial orders against two menthol e-cigarette products currently marketed by RJ Reynolds Vapor Company under the Vuse Solo brand
What can the US Food and Drug Administration (FDA)’s proposed new rule on manufacturing practices tell us about the agency’s vision for future regulation of tobacco and e-cigarette products?
Fears have been raised that new product standards proposed by the US Food and Drug Administration (FDA) to protect consumer health may be costly to implement and overly burdensome for smaller companies
Tobacco giant Altria has confirmed a previously reported rumour by signing an agreement to buy e-cigarette maker Njoy for at least $2.75bn
A bill has been introduced in the US House of Representatives aiming to force the Food and Drug Administration (FDA) to take stiffer action against disposable e-cigarettes
Altria is reported to be in advanced talks to buy e-cigarette company Njoy for around $2.75bn and plans to divest its stake in Juul Labs. Nothing has been finalised, but an announcement could come this week
The US Food and Drug Administration (FDA) has announced its plans to address the recommendations put forward in a damning independent review of its Center for Tobacco Products (CTP)
ECigIntelligence’s annual survey of US vape stores finds a boost in monthly revenue; increases in product category diversification, disposables stocks and cannabis-derived products; and concerns over FDA requirements and other factors that could slow business
The US Food and Drug Administration (FDA) has for the first time filed civil money penalty (CMP) complaints against four small vaping companies for manufacturing and selling e-liquids without marketing authorisation
Matthew Farrelly will have a lot on his desk, and a lot of big calls to make, as the new director of the Office of Science at the US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP)
Flavours continue to be the main target of the Food and Drug Administration (FDA) in the US when it comes to novel nicotine products, it seems – which could give heated tobacco an advantage over e-cigs
RJ Reynolds Vapor Company plans to challenge the US Food and Drug Administration (FDA)’s rejection of its Vuse menthol vape cartridges, joining a judicial fight that has had mixed results for other companies
The US Food and Drug Administration has denied the premarket tobacco product applications of two menthol e-cigarette products by RJ Reynolds Vapor Company, following the agency’s determination that these products do not meet public health standards
The US Food and Drug Administration’s Center for Tobacco Products (FDA CTP) is “reactive and overwhelmed”, staff are “fatigued”, the industry and public health advocates are “frustrated”, and litigation has “upended” the CTP’s plans
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
